SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-12-055576
Filing Date
2012-10-10
Accepted
2012-10-10 20:29:09
Documents
2
Period of Report
2012-10-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v325403_3.html 3  
1 OWNERSHIP DOCUMENT v325403_3.xml 3 7728
2 EXHIBIT 24 v325403_ex24.htm EX-24 9170
  Complete submission text file 0001144204-12-055576.txt   18374
Mailing Address 18 Desbrosses Street New York NY 10013
Business Address 18 Desbrosses Street NEW YORK NY 10013 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA G. DE GRASSI, 11 MILAN L6 20123
Business Address VIA G. DE GRASSI, 11 MILAN L6 20123 390236515110
Genextra S.p.A. (Reporting) CIK: 0001559515 (see all company filings)

State of Incorp.: L6 | Fiscal Year End: 1212
Type: 3 | Act: 34 | File No.: 001-35668 | Film No.: 121138760